Rapidly Alternating Combination of Cisplatin-based Chemotherapy and Hyperfractionated Accelerated Radiotherapy in Split Course for Stage IIIA and Stage IIIB Non-small Cell Lung Cancer: Results of a Phase I-II Study by the GOTHA Group

By Alberto P.   Mirimanoff R.O.   Mermillod B.   Leyvraz S.   Nagy-Mignotte H.   Bolla M.   Wellmann D.   Moro D.   Brambilla E.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 342-348

Elsevier

Access to resources Recommend Favorite

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer - results of the EORTC 08912 phase I/II study

By Uitterhoeve A.L.J.   Belderbos J.S.A.   Koolen M.G.J.   van der Vaart P.J.M.   Rodrigus P.T.R.   Benraadt J.   Koning C.C.M.   Gonzalez Gonzalez D.   Bartelink H.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 592-600

Elsevier

Access to resources Recommend Favorite

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

By Schiller J.   Tilden D.   Aristides M.   Lees M.   Kielhorn A.   Maniadakis N.   Bhalla S.  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite

Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer

By Lokich J.   Anderson N.   Bern M.   Coco F.   Gotthardt S.   Oliynyk P.   Dow E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 659-663

Elsevier

Access to resources Recommend Favorite

Docetaxel (taxotere(R)) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer

By Le Chevalier T.   Monnier A.   Douillard J.Y.   Ruffie P.   Sun X.S.   Belli L.   Ibrahim N.   Bougon N.   Berille J.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2032-2036

Elsevier

Access to resources Recommend Favorite